Calcium signaling in human airway goblet cells following purinergic activation

Am J Physiol Lung Cell Mol Physiol. 2007 Jan;292(1):L92-8. doi: 10.1152/ajplung.00081.2006. Epub 2006 Sep 1.

Abstract

Despite the general importance of Ca(2+) signaling in signal transduction, and of goblet cell mucin hypersecretion in inflammatory pulmonary diseases, measurement of airway goblet cell intracellular Ca(2+) (Ca(i)(2+)) has not been reported. In this article, we describe the results of experiments measuring Ca(i)(2+) in primary cultures of human bronchial goblet cells after stimulation with the purinergic agonist adenosine 5'-O-(3-thiotriphosphate) (ATPgammaS) and phorbol 12-myristate 13-acetate (PMA). Ca(2+) signaling in human goblet cells after purinergic stimulation follows the classic paradigm of a Ca(i)(2+) transient from a basal activity of 110 nM to a peak response of 260.1 +/- 41.2 nM within 2 min, followed by a long superbasal plateau (155.3 +/- 0.2 nM) between 10 and 15 min. The rise in Ca(i)(2+) appears to result from a mobilization of intracellular stores, because the transient was nearly abolished by inhibition of PLC with the phosphatidylinositol-specific PLC inhibitor U-73122, and it was not affected significantly by removal of extracellular Ca(2+). Loading goblet cells with BAPTA inhibited the ATPgammaS-induced Ca(2+) transient by 86.0 +/- 13.1%, relative to control. Finally, in contrast to the massive effects of high doses of PMA (300 nM) on mucin secretion from goblet cells, phorbol ester stimulated a small (27.1 +/- 7% of the ATPgammaS control peak), brief rise in Ca(i)(2+). This diminutive signal likely denotes a local Ca(2+) gradient, which may be associated with the mucin granule exocytotic process.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adenosine Triphosphate / analogs & derivatives
  • Adenosine Triphosphate / pharmacology
  • Bridged-Ring Compounds / pharmacology
  • Bronchi / cytology
  • Bronchi / drug effects*
  • Bronchi / physiology*
  • Calcium Signaling / drug effects*
  • Cells, Cultured
  • Estrenes / pharmacology
  • Goblet Cells / drug effects*
  • Goblet Cells / physiology*
  • Humans
  • Norbornanes
  • Phosphatidylinositol Diacylglycerol-Lyase / antagonists & inhibitors
  • Phosphodiesterase Inhibitors / pharmacology
  • Purinergic P2 Receptor Agonists*
  • Pyrrolidinones / pharmacology
  • Receptors, Purinergic P2Y2
  • Tetradecanoylphorbol Acetate / pharmacology
  • Thiocarbamates
  • Thiones / pharmacology
  • Type C Phospholipases / antagonists & inhibitors

Substances

  • Bridged-Ring Compounds
  • Estrenes
  • Norbornanes
  • P2RY2 protein, human
  • Phosphodiesterase Inhibitors
  • Purinergic P2 Receptor Agonists
  • Pyrrolidinones
  • Receptors, Purinergic P2Y2
  • Thiocarbamates
  • Thiones
  • 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione
  • adenosine 5'-O-(3-thiotriphosphate)
  • tricyclodecane-9-yl-xanthogenate
  • Adenosine Triphosphate
  • Type C Phospholipases
  • Phosphatidylinositol Diacylglycerol-Lyase
  • Tetradecanoylphorbol Acetate